SIGN UP
LOG IN
B
BMY
Bristol-Myers Squibb Co
47.90
-0.79-1.62%After Hours: 47.91 +0.01 +0.02%19:59 04/25 EDT
OPEN/PREV CLOSE48.87/48.69
TODAY RANGE46.96-48.95
VOL16.30M
MARKET CAP97.48B
52 WEEK RANGE37.77-62.65
AVG VOL (3M)13.29M
% TURNOVER0.80%
TURNOVER--
P/E (TTM)17.98
% RANGE4.04%
EPS(TTM)2.664
P/E(FORWARD)10.21
P/B5.88
BVPS8.14
DIVIDEND2.480
P/S1.989
BETA--
DIV YIELD5.18%
FREE FLOAT MKT CAP97.40B
SHARES OUTSTANDING2.04B
NEXT EARNINGS--
FREE FLOAT2.03B
LOT SIZE1
EX-DIV DATE04/04/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·11h ago
Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus
Seeking Alpha·13h ago
No misses here: Healthcare earnings sweep past Wall Street estimates
Seeking Alpha·16h ago
Immunocore Holdings: A Name On My Watch List
The Motley Fool·1d ago
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
Seeking Alpha·1d ago
What Moved Markets This Week
Seeking Alpha·1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of April 27
NASDAQ·2d ago
Validea Detailed Fundamental Analysis - BMY
Seeking Alpha·2d ago
5 Positives From Bristol-Myers Squibb's Q1 2025 Results
Seeking Alpha·2d ago
Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?
TipRanks·2d ago
Bristol Myers price target lowered to $52 from $54 at UBS
Seeking Alpha·2d ago
Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.